Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Other financing activities (2016 - 2023)

Jaguar Health (JAGX) has disclosed Other financing activities for 7 consecutive years, with $6000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Other financing activities changed N/A to $6000.0 in Q4 2023 year-over-year; TTM through Jun 2024 was -$14000.0, a 101.25% decrease, with the full-year FY2023 number at $1.2 million, changed N/A from a year prior.
  • Other financing activities was $6000.0 for Q4 2023 at Jaguar Health, up from -$20000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.2 million in Q1 2023 to a low of -$810000.0 in Q4 2019.
  • A 4-year average of $146125.0 and a median of $10500.0 in 2023 define the central range for Other financing activities.
  • Biggest YoY gain for Other financing activities was 792.13% in 2023; the steepest drop was 792.13% in 2023.
  • Jaguar Health's Other financing activities stood at -$810000.0 in 2019, then surged by 106.42% to $52000.0 in 2020, then tumbled by 442.31% to -$178000.0 in 2022, then skyrocketed by 103.37% to $6000.0 in 2023.
  • Per Business Quant, the three most recent readings for JAGX's Other financing activities are $6000.0 (Q4 2023), -$20000.0 (Q3 2023), and $15000.0 (Q2 2023).